BIOSANTECH develops therapeutic AIDS vaccine based on the active substance TAT Oyi.
Automatic translation

Activity area

  • HEALTHTECH
  • PHARMATECH
  • BIOTECH
  • IMMUNOLOGY

Maturity stage

  • Early bird

Key information

Year of creation

2011

Workforce

< 10

Maturity stage

Early bird

Total fundraising amount

803 000 €

Last round table level

Investment

Total fundraising amount

803 000 €

Maximum round table reached

Date Amount Investors Round table
30/06/2014 803 000,00 €